Publications

High-Content Drug Screening in Zebrafish Xenografts Reveals High Efficacy of Dual Mcl-1/Bcl-Xl Inhibition Against Ewing Sarcoma

AuthID
P-013-XGS

Author(s)

Grissenberger, S

Sturtzel, C

Wenninger-Weinzierl, A

Radic-Sarikas, B

Scheuringer, E

Bierbaumer, L

Etienne, V

Némati, F

Pascoal, S

Tötzl, M

Tomazou, EM

Metzelder, M

Putz, EM

Decaudin, D

Delattre, O

Surdez, D

Kovar, H

Halbritter, F

Distel, M

Document Type

Article

Year published

2023

Published

in Cancer Letters, ISSN: 0304-3835

Volume: 554, Pages: 216028

Indexing

Crossref^®6

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.canlet.2022.216028

Source Identifiers

ISSN: 0304-3835

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

High-Content Drug Screening in Zebrafish Xenografts Reveals High Efficacy of Dual Mcl-1/Bcl-Xl Inhibition Against Ewing Sarcoma

Useful Links

Get Help

Federated Authentication (Click on the image)

High-Content Drug Screening in Zebrafish Xenografts Reveals High Efficacy of Dual Mcl-1/Bcl-Xl Inhibition Against Ewing Sarcoma

Useful Links

Get Help